Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou

ZHANG Jinhua; DUAN Yuanyuan; CAO Lina; SUN Jue; LI Hongmei

doi:10.16462/j.cnki.zhjbkz.2024.09.007

Volume 28 Issue 9

Sep. 2024

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2024 > 28(9): 1030-1036

ZHANG Jinhua, DUAN Yuanyuan, CAO Lina, SUN Jue, LI Hongmei. Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007

Citation:

ZHANG Jinhua, DUAN Yuanyuan, CAO Lina, SUN Jue, LI Hongmei. Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007

Citation:

ZHANG Jinhua, DUAN Yuanyuan, CAO Lina, SUN Jue, LI Hongmei. Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(9): 1030-1036. doi: 10.16462/j.cnki.zhjbkz.2024.09.007

PDF( 824 KB)

Investigation of awareness and vaccination willingness for recombinant zoster vaccine among 50 years adults in Wuzhong District, Suzhou

doi: 10.16462/j.cnki.zhjbkz.2024.09.007

1.
Department of Epidemiology and Biostatistics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou 215123, China
2.
Department of Prevention and Health Care, Changqiao People′s Hospital, Wuzhong District, Suzhou City, Suzhou 215128, China
3.
Department of Public Health, Canglang New City Community Health Service Center, Wumenqiao Street, Gusu District, Suzhou City, Suzhou 215128, China

More Information

Corresponding author: LI Hongmei, E-mail: lihongmei@suda.edu.cn
Received Date: 2023-11-07
Rev Recd Date: 2024-04-19

Available Online: 2024-10-24

Publish Date: 2024-09-10

Abstract

Abstract

Objective To investigate the awareness and vaccination willingness rates of recombinant zoster vaccine (RZV) and the influencing factors among adults aged ≥50 years in Wuzhong District, Suzhou City. Methods Residents aged 50 years in Changqiao Sub-district of Wuzhong District were exported from Jiangsu Province vaccination integrated service management information system. According to the proportion of 1/15 of age stratification (50- < 60, 60- < 70, 70 and above), 1 267 people were randomly selected as the survey sample to participate in the telephone questionnaire survey in August 2022.The awareness and vaccination willingness rates of RZV were calculated, and the influencing factors were analyzed by logistic regression model. Results Among 1 147 respondents, 516 (45.0%) were males, and the 60-69 age group accounted for the largest proportion (40.2%). The rates of awareness and vaccination willingness of RZV were 41.33% (n=474) and 28.95% (n=332), respectively. The results of multivariate logistic regression showed that age, occupation, marital status, history of herpes zoster in family members and relatives and friends were associated with the awareness of RZV0. Females (OR=1.683, 95% CI: 1.234-2.296), participants having family members (OR=1.778, 95% CI: 1.175-2.690) and close friends being medical workers (OR=1.956, 95% CI: 1.115-3.434), history of HZ (OR=1.944, 95% CI: 1.366-2.767), and having family members with history of HZ (OR=2.337, 95% CI: 1.698-3.218), history of trivalent or quadrivalent influenza vaccine(split virion), inactivated (influenza vaccine for short) (OR=2.549, 95% CI: 1.813-3.582), and awareness of RZV (OR=4.431, 95% CI: 3.235-6.069) were willing to get RZV (all P < 0.05). Conclusions The rates of awareness and vaccination willingness of RZV are low. Female, having medical workers in family members and close friends, HZ history among participants and family members are promoting factors for RZV vaccination willingness.
- Recombinant zoster vaccine,
- Awareness rate,
- Vaccination willingness

FullText(HTML)

References(13)

References

[1]	邓慧杰, 刘芳勋. 我国带状疱疹流行病学特征及疫苗免疫规划研究进展综述[J]. 中国继续医学教育, 2021, 13(19): 135-138. DOI: 10.3969/j.issn.1674-9308.2021.19.039. Deng HJ, Liu FX. Epidemiological characteristics of herpes zoster and research progress of vaccine immunization program in China[J]. Chin Cont Med Edu, 2021, 13(19): 135-138. DOI: 10.3969/j.issn.1674-9308.2021.19.039.
[2]	王官清, 李晓霞. 带状疱疹的临床流行病学及预防[J]. 中国皮肤性病学杂志, 2018, 32(11): 1325-1330. DOI: 10.13735/j.cjdv.1001-7089.201801079. Wang Guanqing, Li Xiaoxia. Clinical Epidemiology and Prevention of Herpes Zoster[J]. Chinese Journal of Dermatovenereology, 2018, 32(11): 1325-1330. DOI: 10.13735/j.cjdv.1001-7089.201801079.
[3]	中国医疗保健国际交流促进会皮肤科分会, 中华医学会皮肤性病学分会老年性皮肤病研究中心. 带状疱疹疫苗预防接种专家共识[J]. 中华医学杂志, 2022, 102(8): 538-543. DOI: 10.3760/cma.j.cn112137-20210828-01958. China Healthcare International Exchange and Promotion Association Dermatology Branch, Chinese Medical Association Dermatology and Venereology Branch Center for Research on Aging Skin Diseases. Expert consensus on vaccination against herpes zoster[J]. Natl Med J Chin, 2022, 102(8): 538-543. DOI: 10.3760/cma.j.cn112137-20210828-01958.
[4]	Wang YF, Qi JL, Cao H, et al. Immune responses to Varicella-zoster virus glycoprotein E formulated with poly(lactic-co-glycolic acid) nanoparticles and nucleic acid adjuvants in mice[J]. Virol Sin, 2021, 36(1): 122-132. DOI: 10.1007/s12250-020-00261-y.
[5]	Lu L, Suo L, Li J, et al. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China[J]. Hum Vaccin Immunother, 2018, 14(11): 2632-2635. DOI: 10.1080/21645515.2018.1489193.
[6]	席艳君, 王叶子, 吴晓冰, 等. 区域医联体内≥50岁医务人员带状疱疹疫苗接种意愿及影响因素分析[J]. 社区医学杂志, 2019, 17(23): 1468-1472. DOI: 10.19790/j.cnki.JCM.2019.23.04. Xi YJ, Wang YZ, Wu XB, et al. Analysis of willingness and influencing factors of herpes zoster vaccination among medical workers aged 50 or over in regional medical association[J]. J Community Med, 2019, 17(23): 1468-1472. DOI: 10.19790/j.cnki.JCM.2019.23.04.
[7]	Maltz Fraidy, Fidler Brooke. Shingrix: a new gerpes zoster vaccine[J]. PT, 2019, 44(7): 406-433. DOI: 10.1056/NEJMcp1302674.
[8]	陆佳, 陆昕悦, 沈钰涛, 等. 上海市闵行区50岁以上人群流感、肺炎、带状疱疹疫苗接种意愿及其相关因素分析[J]. 中华预防医学杂志, 2022, 56(2): 125-131. DOI: 10.3760/cma.j.cn112150-20210423-00406. Lu J, Lu XY, Shen YT, et al. Analysis of influenza, pneumonia and herpes zoster vaccination willingness and related factors among people over 50 years old in Minhang District, Shanghai[J]. Chin J Prev Med, 2022, 56(2): 125-131. DOI: 10.3760/cma.j.cn112150-20210423-00406.
[9]	仇静, 孙晓冬, 胡家瑜, 等. 2020年5-6月上海市≥50岁成人带状疱疹疫苗接种意愿调查[J]. 中国疫苗和免疫, 2021, 27(3): 307-310, 327. DOI: 10.19914/j.CJVI.2021057. Qiu J, Sun XD, Hu JY, et al. Willingness to receive herpes zoster vaccine and factors influencing willingness among≥50-year-old adults of Shanghai in May-June 2020[J]. Chinese Journal of Vaccines and Immunization, 2021, 27(3): 307-310, 327. DOI: 10.19914/j.CJVI.2021057.
[10]	黄淑雅, 宋静卉, 邢丽媛. 郑州地区50岁居民带状疱疹疫苗接种意愿及影响因素调查[J]. 华南预防医学, 2022, 48(6): 752-755. DOI: 10.12183/j.scjpm.2022.0752. Huang SY, Song JH, Xing LY. Investigation on herpes zoster vaccination willingness and influencing factors among residents aged 50 years and over in Zhengzhou area[J]. South China J Prev Med, 2022, 48(6): 752-755. DOI: 10.12183/j.scjpm.2022.0752.
[11]	Aguilar-Diaz FC, Jimenez-Corona ME, Ponce-de-Leon-Rosales S. Influenza vaccine and healthcare workers[J]. Arch Med Res, 2011, 42(8): 652-657. DOI: 10.1016/j.arcmed.2011.12.006.
[12]	Weinberger B. Vaccination of older adults: influenza, pneumococcal disease, herpes zoster, COVID-19 and beyond[J]. Immun Ageing, 2021, 18(1): 38. DOI: 10.1186/s12979-021-00249-6.
[13]	Yue M, Wang Y, Low CK, et al. Optimal design of populationlevel financial incentives of influenza vaccination for the elderly[J]. Value Health, 2020, 23(2): 200208. DOI: 10.1016/j.jval.2019.08.006.